3-Ethyl-2-methyl-5-(morpholinomethyl)-6,7-dihydro-1H-indol-4(5H)-one hydrochloride

Catalog No. :
ACGFIR708
CAS No. :
15622-65-8
Molecular Formula :
C16H25ClN2O2
Molecular Weight :
312.84

IUPAC Name:3-ethyl-2-methyl-5-(morpholinomethyl)-1,5,6,7-tetrahydro-4H-indol-4-one hydrochloride

3-Ethyl-2-methyl-5-(morpholinomethyl)-6,7-dihydro-1H-indol-4(5H)-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g99%$148.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Ethyl-2-methyl-5-(morpholinomethyl)-6,7-dihydro-1H-indol-4(5H)-one hydrochloride
IUPAC Name3-ethyl-2-methyl-5-(morpholinomethyl)-1,5,6,7-tetrahydro-4H-indol-4-one hydrochloride
MDL No.MFCD01718304
Molecular FormulaC16H25ClN2O2
Molecular Weight312.84
SMILESO=C1C2=C(NC(C)=C2CC)CCC1CN3CCOCC3.[H]Cl
InChI KeyGQWNECFJGBQMBO-UHFFFAOYSA-N
Synonym3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one hydrochloride | Lidone | Moban | MOLINDONE HYDROCHLORIDE [MART.] | DTXCID3025417 | MLS001333061 | Molindone hydrochloride | 3-Ethyl-2-Methyl-5-(4-Morpholin-4-Iumylmethyl)-1,5,6,7-T
CAS No.15622-65-8
PubChem CID9883259

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301
Precautionary Statement(s)
P301+P310

Synthetic Route by SureRoute

1. ACGFIR708 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFOZU698 route compound structure diagram
    ACFOZU6985625-90-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFIR708 route product structure diagram
    ACGFIR70815622-65-8 In Stock
Inquiry

2. ACGFIR708 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGFIR708 route product structure diagram
    ACGFIR70815622-65-8 In Stock
Inquiry

Comments (0)